Federal Contractor Profile
Lovelace Biomedical Research Institute
Federal contracting record: $137M obligated across 169 awards from 6 agencies, FY 2016–2026.
Company Profile
Parent UEI (Unique Entity Identifier)
MBT9RXJJ7428
CAGE Code
4BSR8
Registered Entities (UEIs)
3 under this organization
Address
1101 YALE BLVD NE, ALBUQUERQUE, NM, 871063834
First Federal Award
Oct 6, 2015
Most Recent Award
Sep 15, 2026
Federal Sales Analytics
Toggle between trend, agency drilldown, and treemap. Use the period selector to focus the time window.
Hover any bar for YoY change + award count. Current fiscal year shown at reduced opacity (partial year).
Top Federal Agencies
- Department of Health and Human Services$129M
96.0% of total obligations
- Department of Defense$5.4M
4.0% of total obligations
- Department of Veterans Affairs$0
0.0% of total obligations
- General Services Administration$0
0.0% of total obligations
- Department of Homeland Security$0
0.0% of total obligations
- Department of the Interior-$18K
-0.0% of total obligations
Top NAICS Activity
Recent Federal Awards
| Date | Agency | NAICS | Description | Amount |
|---|---|---|---|---|
| Sep 14, 2026 | Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS | 541690 | NICOTINE FLUX: INVESTIGATING THE IMPACT OF ENDS OUTPUT POWER AND HEATING ELEMENT ON ABUSE LIABILITY | $3.0M |
| Aug 21, 2026 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541714 | RTOR BIO-AMT-2312: ASSESSMENT OF THE THERAPEUTIC POTENTIAL OF CHLOROQUINE AND OSELTAMIVIR IN TWO (2) LETHAL MODELS OF INFLUENZA A H5N1 | $3.7M |
| Aug 5, 2026 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 541715 | CHARACTERIZATION OF A NON-PARALYZING BONT-BASED BIOPHARMACEUTICAL FOR THE TREATMENT OF NEUROPATHIC PAIN | $351K |
| Jul 17, 2026 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541714 | BIO-AMT-2301: IDIQ CONTRACT MANAGEMENT SUPPORT ACTIVITIES | $22K |
| Jun 22, 2026 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 541715 | EFFICACY AND SAFETY EVALUATION OF LEAD GENE THERAPY CANDIDATE IN NEUROMUSCULAR JUNCTION (NMJ) DISEASE MOUSE MODELS AND BIOANALYTICAL ASSAY METHODS DEVELOPMENT | $303K |
| May 29, 2026 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 541715 | EFFICACY AND SAFETY EVALUATION OF A LEAD GENE THERAPY CANDIDATE IN METHYL MELANOMIC ACIDEMIA (MMAB) DISEASE MOUSE MODELS AND BIOANALYTICAL ASSAY METHODS DEVELOPMENT. | $86K |
| May 29, 2026 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 541712 | NON-CLINICAL SAFETY ASSESSMENT OF GENE THERAPY (PCCA, MMAB, DOK7 AND COLQ) TO SUPPORT PLATFORM GENE THERAPY FOR CONGENITAL MYASTHENIC DISEASES (DOK7, COLQ) AND ACIDEMIA (PCCA, MMAB) | $1.3M |
| May 7, 2026 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541714 | RADNUC 2201: PERFORMANCE VERIFICATION OF INSTITUTIONAL RADIATION DOSE RESPONSE FOR ACUTE RADIATION SYNDROME (ARS) ANIMAL MODELS (RODENT, RABBIT, MINIPIG, OR NON-HUMAN PRIMATE [NHP]) | $148K |
| Apr 1, 2026 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 541715 | THE CONTRACTOR SHALL PERFORM THE TRANSFER, VALIDATION AND QUALIFICATION OF BIOANALYTICAL METHODS FOR DETECTION OF CABOTEGRAVIR AND LEVONORGESTREL IN RAT AND NONHUMAN PRIMATE PLASMA | $55K |
| Sep 30, 2025 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 541715 | EVALUATION AND TESTING SERVICES (ETS) FOR VACCINES AND OTHER BIOLOGICS FOR INFECTIOUS DISEASES. | $10K |
| Sep 22, 2025 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541714 | RADNUC 2201: PERFORMANCE VERIFICATION OF INSTITUTIONAL RADIATION DOSE RESPONSE FOR ACUTE RADIATION SYNDROME (ARS) ANIMAL MODELS (RODENT, RABBIT, MINIPIG, OR NON-HUMAN PRIMATE [NHP]) | $2.0M |
| Sep 19, 2025 | Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS | 541380 | SOLE SOURCE AWARD OF A 24-MONTH PERIOD, FIRM FIXED PRICE (FFP), ENDS TOXICOLOGICAL STUDIES FOR CENTER FOR TOBACCO PRODUCTS (CTP). | $7.1M |
| Aug 27, 2025 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 541715 | THE CONTRACTOR SHALL PERFORM THE TRANSFER, VALIDATION AND QUALIFICATION OF BIOANALYTICAL METHODS FOR DETECTION OF CABOTEGRAVIR AND LEVONORGESTREL IN RAT AND NONHUMAN PRIMATE PLASMA | $139K |
| Jul 17, 2025 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541714 | BIO-AMT-2301: IDIQ CONTRACT MANAGEMENT SUPPORT ACTIVITIES | $21K |
| Jul 9, 2025 | Department of DefenseARMY MED RES ACQ ACTIVITY | 511210 | LICENSE AND MAINTENANCE SUPPORT, ON-SITE SUPPORT SERVICES FOR VSP WRAIR. | $42K |
| Jun 30, 2025 | Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS | 541380 | STUDY OF E-CIGARETTE AEROSOL TOXICITY IN IN VIVO NONCLINICAL MODELS. | $9.8M |
| May 19, 2025 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 541712 | NON-CLINICAL SAFETY ASSESSMENT OF GENE THERAPY (PCCA, MMAB, DOK7 AND COLQ) TO SUPPORT PLATFORM GENE THERAPY FOR CONGENITAL MYASTHENIC DISEASES (DOK7, COLQ) AND ACIDEMIA (PCCA, MMAB) | $1.7M |
| Sep 20, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 541715 | CHARACTERIZATION OF A DOWNSTREAM GENE THERAPEUTIC FOR THE REPARATIVE TREATMENT OF SEVERE FRACTURES PERIOD OF PERFORMANCE SEPTEMBER 24, 2020 - NOVEMBER 23, 2021 | $133K |
| Sep 17, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 541715 | CHARACTERIZATION OF A NON-ADDICTIVE SMALL MOLECULE THERAPEUTICS FOR THE MANAGEMENT OF NON-CANCER PAIN PERIOD OF PERFORMANCE SEPTEMBER 18, 2020 - SEPTEMBER 17, 2022 | $121K |
| Aug 27, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NHLBI | 541380 | 24-015894 NHLBI POPULATION SCIENCES BRANCH REQUIRES PULMONARY FUNCTION TESTING TO DETERMINE IF THE FLEXIVENT METHOD OF PULMONARY FUNCTION TESTING IS SUITABLE TO BE USED IN A LARGER STUDY. | $17K |
| Aug 19, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 541715 | EFFICACY AND SAFETY EVALUATION OF A LEAD GENE THERAPY CANDIDATE IN PROPIONIC ACIDEMIA (PA) DISEASE MOUSE MODELS AND BIOANALYTICAL ASSAY METHODS DEVELOPMENT. PERIOD OF PERFORMANCE SEPTEMBER 25, 2020 - SEPTEMBER 24, 2022 | $48K |
| Aug 14, 2024 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541714 | RADNUC 2201: PERFORMANCE VERIFICATION OF INSTITUTIONAL RADIATION DOSE RESPONSE FOR ACUTE RADIATION SYNDROME (ARS) ANIMAL MODELS (RODENT, RABBIT, MINIPIG, OR NON-HUMAN PRIMATE [NHP]) | $1.7M |
| Aug 6, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 541714 | KICK-OFF MEETING FOR THE PHARMACOLOGY STUDIES AND ANIMAL MODEL DEVELOPMENT AND RELATED SERVICES FOR DRUG DEVELOPMENT IDIQ CONTRACT. | $1K |
| Aug 1, 2024 | Department of DefenseARMY MED RES ACQ ACTIVITY | 511210 | LICENSE AND MAINTENANCE SUPPORT, ON-SITE SUPPORT SERVICES FOR VSP WRAIR. | $225K |
| Jul 18, 2024 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541714 | BIO-AMT-2301: IDIQ CONTRACT MANAGEMENT SUPPORT ACTIVITIES | $37K |
Want to win work like Lovelace Biomedical Research Institute?
Their contracts will eventually end — and when they do, the government has to award that work again. Mindy tells you up to a year early, so you can be ready to compete for it.